AngioGenex
New York
About AngioGenex
AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $875.0K
- Funding stage: IPO
- Last round: Series Unknown (Jan 2005)
- Ticker: otcpink:AGGX
- Website: angiogenex.com
- Phone: (347) 468-6799
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/angiogenex-2067939 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.